Trials / Completed
CompletedNCT01211860
Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects
A Multiple-Dose Pharmacokinetic Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Subjects With Elevated Fasting Triglyceride Levels
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Essentialis, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Once a day oral administration with DCCR is the optimal dosing regimen
Detailed description
POPULATION The population will consist of generally healthy subjects with elevated fasting triglyceride levels in the range of ≥ 150 mg/dL and ≤ 1500 mg/dL at the Screening Visit. Number of Subjects A total of 10 subjects will be enrolled in the study at 1 site in the USA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diazoxide Choline Controlled-Release Tablet | DCCR 290 mg once a day for 10 days |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-09-30
- Last updated
- 2014-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01211860. Inclusion in this directory is not an endorsement.